-+ 0.00%
-+ 0.00%
-+ 0.00%

What Does ICG (LSE:ICG) Court Approval Mean For Shareholders?

Simply Wall St·11/11/2026 09:22:26
Listen to the news
  • Irish Continental Group (LSE:ICG) has received High Court of Ireland approval for its acquisition by Bluefin Bidco Limited.
  • The court sanctioned scheme of arrangement will result in Bluefin Bidco acquiring the entire issued share capital of ICG.
  • ICG's shares are set to be removed from Euronext Dublin and the London Stock Exchange once the scheme becomes effective.
  • The High Court sanction of Bluefin Bidco's scheme only captures one part of ICG's story for investors. We have also flagged 1 warning sign for ICG.

ICG is not the only transport related business affected by takeover and delisting trends, so it can be useful to compare it with peers through our screener containing 5 high quality undiscovered gems.

LSE:ICG Earnings & Revenue Growth as at Nov 2026
LSE:ICG Earnings & Revenue Growth as at Nov 2026

ICG operates as a private equity specialist in both direct deals and fund of funds, so this takeover touches a business that allocates capital across a wide range of underlying investments rather than a single operating asset. For you as an investor, the acquisition involves a £5.3b asset manager within the broader capital markets sector in GB.

5 things going right for ICG that this headline doesn't cover.

How the Bluefin Bidco deal intersects with the ICG Narrative

The takeover news goes straight to the heart of ICG’s Narrative, which centres on a shift towards higher fee strategies and fee related earnings rather than simply more assets under management. This acquisition tests whether that fee engine and product mix are attractive enough for a buyer to take the whole platform private.

"ICG’s fee related earnings reached £350m in FY26 with a 47% FRE margin and higher fee rate strategies now providing more than 75% of management fees..."

See how the full story points towards a £25.11 fair value for ICG.

The sanctioned scheme effectively freezes the public-market chapter of ICG at a point where the business has already pivoted towards higher returning, higher fee strategies. For readers tracking the Narrative, the key question is whether Bluefin Bidco is paying to secure that growing fee mix and the £2.6b balance sheet that seeds new funds, rather than waiting to see more half year numbers like the recent £532.1m revenue and £234.3m net income.

This deal also crystallises one of the main tensions in the thesis. The Narrative hinges on converting fundraising momentum, the Amundi partnership and the $19b non fee earning AUM into sustained fee income, while analysts still flag execution risk and competition for private market deals, including from groups such as 3i Group and Deutsche Beteiligungs, as potential brakes on margins.

To make sense of news like this, you need a view on where ICG is trying to take its fee model and product mix, which is exactly what a well built Narrative helps you pin down.

Add ICG to your Watchlist and get alerts as these catalysts play out.